Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO
- Conditions
- VA-ECMO
- Registration Number
- NCT07141524
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Brief Summary
The aim of this study is to characterize ventilation/perfusion (V/Q) matching in adult patients receiving peripheral VA ECMO support while on mechanical ventilation, and to evaluate the impact of PEEP titration guided by Electrical Impedance Tomography (EIT) and esophageal pressure measurements on lung mechanics and V/Q optimization.
- Detailed Description
We hypothesize that an individualized PEEP titration guided by esophageal pressure measurements and Electrical Impedance Tomography can reduce lung overdistention, enhance lung recruitment, and improve V/Q matching by optimizing regional ventilation and perfusion also in VA ECMO.
Our objectives are:
1. To describe V/Q matching in patients undergoing mechanical ventilation during peripheral VA ECMO support.
2. To explore the impact of PEEP titration based on esophageal pressure and EIT in terms of lung mechanics and V/Q matching.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 10
- Adults (≥18 years) undergoing mechanical ventilation during peripheral VA ECMO support for cardiogenic shock, cardiac arrest, or refractory heart failure.
- On ECMO support for at least 6 hours
- Swan-Ganz catheter required as standard clinical care
- Clinically stable in the estimation of the study investigator
- Contraindications to EIT (e.g., presence of pacemaker or IMPELLA device for electrical interference)
- Patients without pulmonary flow (non-pulsatile pulmonary prSessure)
- Patients with known pulmonary embolism
- Imminent withdrawal of life support
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method V/Q match 1 hour The primary goal of this physiological study is to measure improvements in ventilation-perfusion matching and quantify shunt fraction. The study aims to document measurable changes expressed as a percentage improvement from baseline.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beth Israel Deaconess Medical Center
🇺🇸Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center🇺🇸Boston, Massachusetts, United StatesArian Karimitar, PhDContact6176328056akarimit@bidmc.harvard.eduMaurizio Bottiroli, MDContact6176673112mbottiro@bidmc.harvard.edu